John Franklin Fowler

Insider Reports History

Entity
Individual
Location
C/O Kezar Life Sciences, Inc., 4000 Shoreline Court, Suite 300, South San Francisco, CA
Signature
/s/ Marc Belsky, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Franklin Fowler:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kezar Life Sciences, Inc. CEO, Director Employee Stock Option (right to buy) 580K Jul 24, 2023 Direct

Insider Reports Filed by John Franklin Fowler

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KZR Kezar Life Sciences, Inc. Jul 24, 2023 10 $0 4 Jul 26, 2023 CEO, Director
KZR Kezar Life Sciences, Inc. Jan 8, 2023 1 $0 4 Jan 10, 2023 CEO, Director
KZR Kezar Life Sciences, Inc. Nov 10, 2022 2 $24.3K 4 Nov 14, 2022 CEO, Director
KZR Kezar Life Sciences, Inc. Jan 5, 2022 1 $0 4 Jan 7, 2022 CEO, Director
KZR Kezar Life Sciences, Inc. Dec 14, 2021 2 $6.93K 4 Dec 15, 2021 CEO, Director